Your browser doesn't support javascript.
loading
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
Hung, Ivan Fan-Ngai; Cheng, Vincent Chi-Chung; Li, Xin; Tam, Anthony Raymond; Hung, Derek Ling-Lung; Chiu, Kelvin Hei-Yeung; Yip, Cyril Chik-Yan; Cai, Jian-Piao; Ho, Deborah Tip-Yin; Wong, Shuk-Ching; Leung, Sally Sau-Man; Chu, Man-Yee; Tang, Milky Oi-Yan; Chen, Jonathan Hon-Kwan; Poon, Rosana Wing-Shan; Fung, Agnes Yim-Fong; Zhang, Ricky Ruiqi; Yan, Erica Yuen-Wing; Chen, Lin-Lei; Choi, Charlotte Yee-Ki; Leung, Kit-Hang; Chung, Tom Wai-Hin; Lam, Sonia Hiu-Yin; Lam, Tina Poy-Wing; Chan, Jasper Fuk-Woo; Chan, Kwok-Hung; Wu, Tak-Chiu; Ho, Pak-Leung; Chan, Johnny Wai-Man; Lau, Chak-Sing; To, Kelvin Kai-Wang; Yuen, Kwok-Yung.
Afiliação
  • Hung IF; Infectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, Ch
  • Cheng VC; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China; Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Li X; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Tam AR; Infectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Hung DL; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chiu KH; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Yip CC; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Cai JP; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Ho DT; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Wong SC; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China; Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Leung SS; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chu MY; Department of Medicine, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China.
  • Tang MO; Infectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chen JH; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Poon RW; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Fung AY; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Zhang RR; Infectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, Ch
  • Yan EY; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chen LL; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Choi CY; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Leung KH; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chung TW; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Lam SH; Department of Radiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Lam TP; Department of Radiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Chan JF; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chan KH; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Wu TC; Department of Medicine, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China.
  • Ho PL; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chan JW; Department of Medicine, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China.
  • Lau CS; Infectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • To KK; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Yuen KY; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: kyyuen@hku.hk.
Lancet Infect Dis ; 20(9): 1051-1060, 2020 09.
Article em En | MEDLINE | ID: mdl-32539986
BACKGROUND: A cruise ship is a closed-off environment that simulates the basic functioning of a city in terms of living conditions and interpersonal interactions. Thus, the Diamond Princess cruise ship, which was quarantined because of an onboard outbreak of COVID-19 in February, 2020, provides an opportunity to define the shedding pattern of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient antibody responses before and after the onset of symptoms. METHODS: We recruited adult (≥18 years) passengers from Hong Kong who had been on board the Diamond Princess cruise ship docked in Yokohama, Japan in February, 2020. All participants had been found to be negative for SARS-CoV-2 by RT-PCR 4 days before disembarking and were transferred to further quarantine in a public estate in Hong Kong, where they were recruited. Participants were prospectively screened by quantitative RT-PCR (RT-qPCR) of nasopharyngeal and throat swabs, and serum IgG and IgM against internal nucleoprotein and the surface spike receptor-binding protein (RBD) of SARS-CoV-2 at baseline (upon entering quarantine) and on days 4, 8, and 12 of quarantine. FINDINGS: On Feb 22, 2020, 215 adults were recruited, of whom nine (4%; 95% CI 2-8) were positive for SARS-CoV-2 by RT-qPCR or serology and were hospitalised. Of these nine patients, nasopharyngeal swab RT-qPCR was positive in eight patients (89%; 57-99) at baseline. All nine patients were positive for anti-RBD IgG by day 8. Eight (89%; 57-99) were simultaneously positive for nasopharyngeal swab RT-PCR and anti-RBD IgG. One patient who was positive for anti-RBD IgG and had a negative viral load had multifocal peripheral ground-glass changes on high-resolution CT that were typical of COVID-19. Five patients (56%; 27-81) with ground-glass changes on high-resolution CT were found to have higher anti-nucleoprotein-IgG OD values on day 8 and 12 and anti-RBD IgG OD value on day 12 than patients without ground-glass changes. Six (67%; 35-88) patients remained asymptomatic throughout the 14-day quarantine period. INTERPRETATION: Patients with COVID-19 can develop asymptomatic lung infection with viral shedding and those with evidence of pneumonia on imaging tend to have an increased antibody response. Positive IgG or IgM confirmed infection of COVID-19 in both symptomatic and asymptomatic patients. A combination of RT-PCR and serology should be implemented for case finding and contact tracing to facilitate early diagnosis, prompt isolation, and treatment. FUNDING: Shaw Foundation Hong Kong; Sanming-Project of Medicine (Shenzhen); High Level-Hospital Program (Guangdong Health Commission).
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Surtos de Doenças / Eliminação de Partículas Virais / Infecções por Coronavirus / Soroconversão / Betacoronavirus País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Surtos de Doenças / Eliminação de Partículas Virais / Infecções por Coronavirus / Soroconversão / Betacoronavirus País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article